期刊文献+

不同严重程度急性缺血性卒中患者静脉溶栓预后的影响因素分析 被引量:17

Factors related to therapeutic outcomes of intravenous thrombolysis in stroke patients with different severity
下载PDF
导出
摘要 目的:观察不同严重程度急性缺血性卒中(AIS)患者静脉溶栓远期预后和出血转化的影响因素。方法:回顾性分析2009年6月至2013年12月在浙江大学医学院附属第二医院神经内科因AIS接受静脉溶栓治疗患者的资料,根据美国国立卫生研究院卒中量表(NIHSS)将患者分为轻度(≤8分)、中度(9~15分)、重度(≥16分)三组,分别观察影响患者溶栓后的预后(3月时改良Rankin评分≤2分定义为预后良好)及发生出血转化的因素。结果:共365例患者纳入分析:轻度134例、中度121例、重度110例。轻度AIS患者中,年龄[ OR=0.937,95%可信区间(CI):0.898~0.978;P=0.003]、基线NIHSS(OR=0.732,95%CI:0.564~0.950;P=0.019)、发病至治疗时间在270 min内( OR=4.109,95%CI:1.441~11.719;P=0.008)是预后良好的独立影响因素;而基线血糖( OR=1.326,95%CI:1.009~1.743;P=0.043)是发生脑实质出血型出血转化的独立影响因素。中度AIS患者中,年龄( OR=0.954,95%CI:0.924~0.984;P=0.003)、基线NIHSS ( OR=0.760,95%CI:0.619~0.933;P=0.009)是预后良好的独立影响因素;而心房颤动( OR=3.307,95%CI:1.140~9.596;P=0.028)、收缩压( OR=0.967, 95%CI:0.943~0.991;P=0.008)是发生出血性梗死型出血转化的独立影响因素,心房颤动( OR=36.972,95%CI:1.770~772.462;P=0.02)是发生脑实质出血型出血转化的独立影响因素。重度AIS患者中,基线NIHSS ( OR=0.808,95%CI:0.677~0.963;P=0.018)是预后良好的独立影响因素,未发现发生溶栓后出血转化的独立影响因素。结论:对于不同严重程度的AIS患者,影响静脉溶栓后远期预后及发生出血转化的影响因素不尽相同;发病至治疗时间在270 min内是轻度AIS患者静脉溶栓后3个月预后良好的独立影响因素;心房颤动是中度AIS患者静脉溶栓后发生出血转化的独立影响因素。 Objective: To investigate the factors related to therapeutic outcomes of intravenous thrombolysis in patients with acute ischemic stroke ( AIS ) of different severity. Methods: Clinical data of patients with AIS treated with intravenous thrombolysis in the Second Affiliated Hospital , Zhejiang University School of Medicine between June 2009 and December 2013 were retrospectively reviewed .According to National Institutes of Health Stroke Scale ( NIHSS ) , patients were categorized as mild stroke (≤8 , n=134 ) , moderate stroke ( 9-15 , n=121 ) and severe stroke (≥16 , n=110 ) .The good outcome was defined as modified Rankin Scale ≤2 .The factors related to functional outcomes and hemorrhagic transformation ( HT) were analyzed and compared among 3 groups.Results:Among 365 enrolled patients , good outcomes in 3 groups were 78 .4% ( 105/134 ) , 47 .9% ( 58/121 ) and 24 .5%( 27/110 ) , respectively.In patients with mild stroke, age (OR=0.937, 95%CI:0.898-0.978;P=0.003), baseline NIHSS (OR=0.732, 95%CI:0.564 -0.950; P =0.019), onset to needle time (ONT) within 270 min (OR=4.109, 95%CI:1.441-11.719;P=0.008 ) independently predicted good outcome , while baseline glucose ( OR =1.326, 95%CI:1.009 -1.743; P =0.043 ) was independently associated with parenchymal hematoma ( PH ) .In patients with moderate stroke , age ( OR =0 .954 , 95%CI: 0.924 -0.984; P =0.003) and baseline NIHSS (OR =0.760, 95%CI:0 .619 -0 .933; P =0 .009 ) independently predicted good outcome , while atrial fibrillation ( OR=3 .307 , 95%CI:1 .140~9 .596; P=0 .028 ) and systolic pressure ( OR=0.967, 95%CI:0.943~0.991;P=0.008) was independently associated with hemorrhagic infaction .Atrial fibrillation ( OR=36 .972 , 95%CI:1 .770-772 .462;P=0 .02 ) was independently associated with PH . In patients with severe stroke , baseline NIHSS (OR=0.808, 95%CI:0.677 -0.963; P =0.018) independently predicted good outcome , while no independent risk factors of HT was found . Conclusion:For different severity of AIS patients , the related factors of functional outcome and HT after thrombolysis were different .
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2015年第1期54-60,共7页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省杰出青年科学基金(LR12H09001) 浙江省科技厅重大科技专项计划(2013C03043-3) 浙江省中医药(中西医结合)重点学科资助项目(2012-XK-A33)
关键词 心房颤动 急性病 脑缺血/药物疗法 卒中/药物疗法 血栓溶解疗法 出血 预后 回顾性研究 Atrial fibrillation Acute disease Brain ischemia/drug therapy Stroke /drug therapy Thrombolytic therapy Hemorrhage Prognosis Retrospective studies
  • 相关文献

参考文献3

二级参考文献20

共引文献3697

同被引文献154

  • 1樊琦,薛艺东,石倩.脑白质疏松与AIS静脉溶栓预后相关性研究进展[J].世界最新医学信息文摘,2020(41):94-95. 被引量:1
  • 2栾璟煜,王伊龙.阿替普酶急性卒中溶栓安全应用的监测研究(SITS-MOST)[J].中国卒中杂志,2007,2(12):1009-1014. 被引量:13
  • 3黄永光,李永鸿,李荣.增加型体外反搏(EECP)治疗脑卒中后血管性认知障碍的影响[J].现代医院,2006,6(12):36-38. 被引量:2
  • 4Silbemagel G,Fauler G, Genser B, et al. Intestinal cholesterolabsorption,treatment with atorvastatin,and cardiovascular risk inhemodialysis patients [ J ]. J Am Coll Cardiol, 2015,65 (21):2291 -2298.
  • 5Shabari FR, George J, Cuchiara MP, et al. Improved hemodynamicswith a novel miniaturized intra - aortic axial flow pump in a porcinemodel of acute left ventricular dysfunction [ J]. ASAIO J, 2013 , 59(3): 240-245.
  • 6Schwartz GG, Abt M, Bao W, et al. Fasting triglycerides predictrecurrent ischemic events in patients with acute coronary syndrometreated with statins [ J ]. J Am Coll Cardiol, 2015,65 (21):2267 -2275.
  • 7Sahl6n A, Wu E,RUck A, et al. Relation between N - terminalpro - brain natriuretic peptide levels and response to enhanced externalcounterpulsation in chronic angina pectoris [ J ]. Coron Artery Dis,2014, 25 (1): 45-51.
  • 8Kolyva C, Pantalos GM, Pepper JR, et al. Does conventional intra -aortic balloon pump trigger timing produce optimal hemodynamiceffects in vivo? [ J]. Int J Artif Organs,2015 ,38(3) : 146 - 153.
  • 9Adams HP Jr, Bendixen BH, Kappelle U, et al. Classifica- tion of subtype of acute ischemic stmke. Detlnhlons for use in a muhicenter clinical trial. TOAST. Trial of Org 10172 in Acute stroke Treatment[J]. Stoke,1993,24(1): 35-41.
  • 10Goldstein LB, Barrels C, Davis JN. Interrater reliability of the NIH stroke scale[J]. Arch Neurol, 1989,46 (6) :660- 662.

引证文献17

二级引证文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部